Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Challenges for the FDA: The Future of Drug Safety, Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.

Washington (DC): National Academies Press (US); 2007.

2.

Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation, Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic Events.

Washington (DC): National Academies Press (US); 2011.

3.

Academic analysis of the Institute of Medicine report: The Future of Drug Safety.

Lofstedt RE.

Expert Rev Clin Pharmacol. 2008 Sep;1(5):617-25. doi: 10.1586/17512433.1.5.617.

PMID:
24422734
[PubMed]
4.

The Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa: Global and Local Challenges and Solutions: Summary of a Joint Workshop.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation, Academy of Science of South Africa.

Washington (DC): National Academies Press (US); 2011.

5.

Expanding public-private collaborations to enhance cancer drug development: a report of the Institute of Medicine's workshop series, "Implementing a National Cancer Clinical Trials System for the 21st Century".

Bertagnolli MM, Canetta R, Nass SJ.

Oncologist. 2014 Nov;19(11):1179-85. doi: 10.1634/theoncologist.2014-0240. Epub 2014 Oct 17.

PMID:
25326161
[PubMed - in process]
Free PMC Article
6.

Emerging Safety Science: Workshop Summary.

Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.

Washington (DC): National Academies Press (US); 2008.

8.
9.

The Science and Applications of Synthetic and Systems Biology: Workshop Summary.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2011.

10.

Antibiotic Resistance: Implications for Global Health and Novel Intervention Strategies: Workshop Summary.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2010.

11.

The FDA and drug safety: a proposal for sweeping changes.

Furberg CD, Levin AA, Gross PA, Shapiro RS, Strom BL.

Arch Intern Med. 2006 Oct 9;166(18):1938-42.

PMID:
17030825
[PubMed - indexed for MEDLINE]
12.

Leveraging Food Technology for Obesity Prevention and Reduction Efforts: Workshop Summary.

Institute of Medicine (US) Food Forum.

Washington (DC): National Academies Press (US); 2011.

13.

Fungal Diseases: An Emerging Threat to Human, Animal, and Plant Health: Workshop Summary.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2011.

14.

The Science and Applications of Microbial Genomics: Workshop Summary.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2013.

15.

Rational Therapeutics for Infants and Children: Workshop Summary.

Institute of Medicine (US) Roundtable on Research and Development of Drugs, Biologics, and Medical Devices; Yaffe S, editor.

Washington (DC): National Academies Press (US); 2000.

16.

A Strategic Approach for Funding Research: The Agency for Healthcare Research and Quality's Patient Safety Initiative 2000-2004.

Keyes MA, Ortiz E, Queenan D, Hughes R, Chesley F, Hogan EM.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 4: Programs, Tools, and Products). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

17.

The Institute of Medicine's report on drug safety: constructive and ambitious, but does it go far enough?

Jones JK.

Clin Pharmacol Ther. 2007 Feb;81(2):156-8.

PMID:
17259940
[PubMed - indexed for MEDLINE]
18.

Infectious Disease Movement in a Borderless World: Workshop Summary.

Institute of Medicine (US) Forum on Microbial Threats.

Washington (DC): National Academies Press (US); 2010.

19.

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary.

Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine.

Washington (DC): National Academies Press (US); 2014 Dec 19.

20.

Future Opportunities to Leverage the Alzheimer’s Disease Neuroimaging Initiative: Workshop Summary.

Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.

Washington (DC): National Academies Press (US); 2011.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk